Growth hormone disorders

There are a variety of brands available including Saizen, Norditropin, Omnitrope, Nutropinaq, Zomacton, Gentropin and Humatrope and any of the brands may be prescribed. Prescribing must be by brand name.

Injections are usually via a pen device or autoinjector. These are initiated by a specialist and ongoing supply has the potential to be transferred to primary care.

• To be initiated by paediatric endocrine consultants at specialist tertiary centre only in accordance with NICE TA863 and patients monitored by the hospital.
• In Secondary care, patients are reviewed at 3 weeks then every 6 months for height velocity.
• In Secondary care usually manage the majority of patients who require growth deficiency treatment and guidelines are usually the same or similar to the tertiary provider, Evelina.
• Somatrogon will be reserved for children with learning difficulties and compliance issues.
• Medicines will be delivery to the patient’s home via Healthnet.
• Community nurses are available to support with administration.